日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial

Autogene cevumeran联合或不联合atezolizumab治疗晚期实体瘤:一项I期试验

Lopez, Juanita; Powles, Thomas; Braiteh, Fadi; Siu, Lillian L; LoRusso, Patricia; Friedman, Claire F; Balmanoukian, Ani S; Gordon, Michael; Yachnin, Jeffrey; Rottey, Sylvie; Karydis, Ioannis; Fisher, George A; Schmidt, Marcus; Schuler, Martin; Sullivan, Ryan J; Burris, Howard A; Galvao, Vladimir; Henick, Brian S; Dirix, Luc; Jaeger, Dirk; Ott, Patrick A; Wong, Kit Man; Jerusalem, Guy; Schiza, Aglaia; Fong, Lawrence; Steeghs, Neeltje; Leidner, Rom S; Rittmeyer, Achim; Laurie, Scott A; Gort, Eelke; Aljumaily, Raid; Melero, Ignacio; Sabado, Rachel L; Rhee, Ina; Mancuso, Michael R; Muller, Lars; Fine, Gregg D; Yadav, Mahesh; Kim, Leesun; Leveque, Vincent J P; Robert, Alberto; Darwish, Martine; Qi, Ting; Zhu, Jiawen; Zhang, Jingbin; Twomey, Patrick; Rao, Gautham K; Low, Donald W; Petry, Chris; Lo, Amy A; Schartner, Jill M; Delamarre, Lélia; Mellman, Ira; Löwer, Martin; Müller, Felicitas; Derhovanessian, Evelyna; Cortini, Andrea; Manning, Luisa; Maurus, Daniel; Brachtendorf, Sebastian; Lörks, Verena; Omokoko, Tana; Godehardt, Eva; Becker, Dirk; Hawner, Christine; Wallrapp, Christine; Albrecht, Christian; Kröner, Christoph; Tadmor, Arbel D; Diekmann, Jan; Vormehr, Mathias; Jork, Anette; Paruzynski, Anna; Lang, Maren; Blake, Jonathon; Hennig, Oliver; Kuhn, Andreas N; Sahin, Ugur; Türeci, Özlem; Camidge, D Ross

Efficacy and safety of one-time autologous tumor-infiltrating lymphocyte cell therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

一次性自体肿瘤浸润淋巴细胞疗法治疗复发性和/或转移性头颈部鳞状细胞癌患者的疗效和安全性

Ferris, Robert L MD,; Leidner, Rom S; Chung, Christine H; Jimeno, Antonio; Lee, Sylvia M; Sukari, Ammar; Nieva, Jorge J; Grilley-Olson, Juneko E; Redman, Rebecca; Wong, Stuart J; Villaflor, Victoria M; Misleh, Jamal; Finckenstein, Friedrich Graf; Chou, Jeffrey; Gastman, Brian; Fiaz, Rana; Catlett, Melissa; Yi, Min; Cohen, Ezra E W

FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment

FcγRIIB是一种免疫检查点,可限制肿瘤微环境中靶向Treg细胞的抗体的活性。

David A Knorr # ,Lucas Blanchard # ,Rom S Leidner # ,Shawn M Jensen ,Ryan Meng ,Andrew Jones ,Carmen Ballesteros-Merino ,Richard B Bell ,Maria Baez ,Alessandra Marino ,David Sprott ,Carlo B Bifulco ,Brian Piening ,Rony Dahan ,Juan C Osorio ,Bernard A Fox ,Jeffrey V Ravetch

Cancer's Dark Matter: Lighting the Abyss Unveils Universe of New Therapies

癌症的暗物质:揭开深渊,展现全新疗法的宇宙

Fox, Bernard A; Urba, Walter J; Jensen, Shawn M; Page, David B; Curti, Brendan D; Sanborn, Rachel E; Leidner, Rom S

Perspectives in Melanoma: meeting report from the Melanoma Bridge (December 1st-3rd, 2022-Naples, Italy)

黑色素瘤展望:黑色素瘤桥梁会议报告(2022年12月1日至3日,意大利那不勒斯)

Ascierto, Paolo A; Agarwala, Sanjiv S; Warner, Allison Betof; Ernstoff, Marc S; Fox, Bernard A; Gajewski, Thomas F; Galon, Jérôme; Garbe, Claus; Gastman, Brian R; Gershenwald, Jeffrey E; Kalinski, Pawel; Krogsgaard, Michelle; Leidner, Rom S; Lo, Roger S; Menzies, Alexander M; Michielin, Olivier; Poulikakos, Poulikos I; Weber, Jeffrey S; Caracò, Corrado; Osman, Iman; Puzanov, Igor; Thurin, Magdalena

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

纳武利尤单抗联合放化疗治疗中高危局部晚期头颈部鳞状细胞癌的安全性:RTOG基金会3504

Gillison, Maura L; Ferris, Robert L; Harris, Jonathan; Colevas, A Dimitrios; Mell, Loren K; Kong, Christina; Jordan, Richard C; Moore, Kevin L; Truong, Minh-Tam; Kirsch, Claudia; Chakravarti, Arnab; Blakaj, Dukagjin M; Clump, David A; Ohr, James P; Deeken, John F; Gensheimer, Michael F; Saba, Nabil F; Dorth, Jennifer A; Rosenthal, David I; Leidner, Rom S; Kimple, Randall J; Machtay, Mitchell; Curran, Walter J Jr; Torres-Saavedra, Pedro; Le, Quynh Thu

Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cells

在头颈部鳞状细胞癌患者中,新辅助抗OX40(MEDI6469)疗法可激活并扩增抗原特异性肿瘤浸润T细胞。

Rebekka Duhen ,Carmen Ballesteros-Merino ,Alexandra K Frye ,Eric Tran ,Venkatesh Rajamanickam ,Shu-Ching Chang ,Yoshinobu Koguchi ,Carlo B Bifulco ,Brady Bernard ,Rom S Leidner ,Brendan D Curti ,Bernard A Fox ,Walter J Urba ,R Bryan Bell ,Andrew D Weinberg

Enhancing clinical and immunological effects of anti-PD-1 with belapectin, a galectin-3 inhibitor

利用半乳糖凝集素-3抑制剂贝拉普汀增强抗PD-1的临床和免疫学效应

Curti, Brendan D; Koguchi, Yoshinobu; Leidner, Rom S; Rolig, Annah S; Sturgill, Elizabeth R; Sun, Zhaoyu; Wu, Yaping; Rajamanickam, Venkatesh; Bernard, Brady; Hilgart-Martiszus, Ian; Fountain, Christopher B; Morris, George; Iwamoto, Noriko; Shimada, Takashi; Chang, ShuChing; Traber, Peter G; Zomer, Eliezer; Horton, J Rex; Shlevin, Harold; Redmond, William L

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

局部区域 T 细胞免疫治疗平台用于控制 HNSCC 肿瘤切除后复发

Shay Sharon, Jason R Baird, Shelly Bambina, Gwen Kramer, Tiffany C Blair, Shawn M Jensen, Rom S Leidner, R Bryan Bell, Nardy Casap, Marka R Crittenden, Michael J Gough

Delayed immune-related events (DIRE) after discontinuation of immunotherapy: diagnostic hazard of autoimmunity at a distance

免疫治疗停止后出现的迟发性免疫相关事件(DIRE):远距离自身免疫的诊断风险

Couey, Marcus A; Bell, R Bryan; Patel, Ashish A; Romba, Meghan C; Crittenden, Marka R; Curti, Brendan D; Urba, Walter J; Leidner, Rom S